The gap
Two facts that belong together
People hold DNA files. People are asking about peptides. Almost nobody hands a licensed clinician a single graded packet.
Flagship platform · Decision support
Peptide options, matched to the genome.
PeptOdyssey turns a genetic file into a structured set of peptide options a licensed clinician can review. Evidence grades and citations travel with the dossier so unknowns stay visible.
People are using peptides faster than the facts. Ancestry companies hold genomes; peptide clinics ship vials. PeptOdyssey writes the graded options list a licensed clinician can review. Success is every statement having a grade, and a clinician who can see why.
Genome in, options outA licensed clinician stays in the loopEvidence grades
Status: Shipping platform (Detect). Design is Stage A. Delivery stays research.
Detect. Design. Deliver. Software first.
Detect is the software we ship — a graded options list for a licensed clinician. Design is Stage A visualization. Deliver is research.
What’s inside
The engine annotates. The dossier reports. A clinician decides.
Luxury-clinic calm. Fast to load. Two to three colors on purpose — so the message does the work.
Options set
A dossier a clinician can read
Priorities, cautions, evidence grades, and open questions. A licensed clinician reviews the packet.
Safety posture
Grades before hype
Approved drugs, compounding caveats, and unapproved compounds are labeled. Where human evidence is thin, the product says so.
Follow-up
How the story continues
Room to fuse genetic priors with measured biomarkers so each check-in can tighten the picture — still under clinical judgment.
Privacy lane
When the file should stay put
PeptOdyssey is the clinic-facing dossier. U4U Privacy is the local-first toolkit when you refuse upload-everything.
Research path
Built to mature
Software ships first. Design is Stage A. Delivery science stays research — labeled as such.
Designed for you
Built to evolve with how care actually happens.
For people
Understand your starting point.
- Bring a genome file you already have (or plan to obtain).
- See peptide-relevant context in plain language.
- Leave with a dossier you can take to a licensed clinician.
For clinicians & partners
A dossier a clinician can read.
- Structured outputs meant to be reviewed by a licensed clinician.
- A path into longitudinal tracking and the broader FMB platform.
- Research and decision-support software from Florida Man Bioscience.
The loop
Detect → Design → Deliver
01
Detect
PeptOdyssey: genome-aware decision support a licensed clinician can read.
02
Design
Structure-guided visualization for peptide and protein work. Stage A software.
03
Deliver
MSP / vector nanodisk research on a longer horizon. Optionality.
Why it matters
A dossier a clinician can read.
Genome in, options out
Upload or ingest a genetic file. Get a clinician-readable packet: context, flags, and options tied to published evidence.
A licensed clinician stays in the loop
The dossier is built to be reviewed by a human with a license.
Evidence grades
Approved drugs, compounding caveats, and unapproved compounds are labeled. Where human evidence is thin, the product says so.
- A licensed clinician reviews the dossier
- Evidence grades and citations travel with the options
- Live path into analysis and tracking
- Privacy toolkit lane when files should stay local
Quick answers
Straight talk.
- What is PeptOdyssey?
- Research and decision-support software from Florida Man Bioscience. A licensed clinician reviews the dossier.
- Who writes the order?
- A licensed clinician. PeptOdyssey produces a structured dossier for that review.
- What happened to PeptidIQ / U4U?
- PeptidIQ was the old name for this platform. U4U is an internal engineering name. Publicly there is one product: PeptOdyssey — engine, dossier, tracker, and iOS research capture.
- What about privacy?
- We offer different trust models: product surfaces when you opt in, and u4u-privacy for local-first work on hardware you control.
- Can I start today?
- Yes — open PeptOdyssey to run a genome analysis, or contact the team for partnership and clinical workflow conversations.
Ready when you are
Take the next step with PeptOdyssey.
Start a PeptOdyssey analysis, explore the privacy toolkit, or talk with the team about how genome-aware options fit your clinic or research workflow.
More from Florida Man Bioscience
Explore the portfolio.
Design lab
Next-gen drug design
Stage A. See the structure on desktop and in VR. Design in software before anyone orders synthesis.
View page →Science-agent OS
Discovery Informatics
Jailed science-agent OS for lab PIs: PI ask → routed evidence → artifacts + METHODS + cannots. Wave 0.
View page →Lab software
CytoGate
Local desktop cytometry for cores and immunology labs. See compensation. Keep the file. Gate on purpose.
View page →Privacy toolkit
U4U Privacy
Local-first consumer genomics. Work a DNA file on hardware you control.
View page →Delivery research
Vector nanodisk
Research-stage delivery optionality for peptide and nucleic-acid payloads.
View page →Parked discovery
Neurocreatine
Parked early discovery — a CNS creatine question.
View page →